VAISHALI PHARMA
Back to Income Statement
|
VAISHALI PHARMA Last 5 Year Revenue History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Net Sales | ₹70 Cr | ₹76 Cr | ₹5,377,389 Cr | ₹60 Cr | ₹75 Cr |
What is the latest Revenue of VAISHALI PHARMA ?
| Year | Revenue |
|---|---|
| Mar2024 | ₹70 Cr |
| Mar2023 | ₹76 Cr |
| Mar2022 | ₹5,377,389 Cr |
| Mar2021 | ₹60 Cr |
| Mar2020 | ₹75 Cr |
How is Revenue of VAISHALI PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2024 | ₹70 Cr | -8.12 | |
| Mar2023 | ₹76 Cr | -100.00 | |
| Mar2022 | ₹5,377,389 Cr | 8,949,387.00 | |
| Mar2021 | ₹60 Cr | -19.98 | |
| Mar2020 | ₹75 Cr | - | |
Compare Revenue of peers of VAISHALI PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VAISHALI PHARMA | ₹130.5 Cr | -2% | -11% | -44.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | -1.4% | 3.6% | -7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,488.0 Cr | 4.4% | 15.9% | 15.6% | Stock Analytics | |
| CIPLA | ₹121,452.0 Cr | -4.9% | -0.8% | 6.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,057.0 Cr | -0.6% | 1.8% | 15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,220.0 Cr | -4.1% | -3.8% | -4.3% | Stock Analytics | |
VAISHALI PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VAISHALI PHARMA | -2% |
-11% |
-44.7% |
| SENSEX | -1.4% |
3.1% |
3.8% |
You may also like the below Video Courses